WeVote

Bill

Bill

S 760

Relates to requiring insurance coverage for epinephrine auto-injectors

2025 Regular Session Introduced by Gustavo Rivera

Overview: S 760 - Relates to requiring insurance coverage for epinephrine auto-injectorsPurpose and Intent: This bill aims to mandate insurance coverage for epinephrine auto-inject

SIGNED CHAP.81
0
WeVote Research Nonpartisan
Bill Summary · S 760

Overview: S 760 - Relates to requiring insurance coverage for epinephrine auto-injectors
Purpose and Intent: This bill aims to mandate insurance coverage for epinephrine auto-injectors, which are essential for individuals with severe allergies. The goal is to improve access to this life-saving medication and reduce the financial burden on patients.

Key Provisions:
- Requires all health insurance plans in the state to cover the cost of epinephrine auto-injectors
- Prohibits insurance companies from imposing any deductibles, copayments, or other cost-sharing requirements for the auto-injectors
- Ensures that patients can obtain the auto-injectors without facing significant out-of-pocket expenses

Affected Parties and Impacts:
- Individuals with severe allergies will have improved access to epinephrine auto-injectors, which can be critical in emergency situations
- Insurance companies will be required to adjust their coverage policies and pricing to accommodate the new mandate
- The state may see a reduction in emergency medical costs related to severe allergic reactions

Procedural and Timeline Considerations:
The bill has been signed into law, becoming effective immediately.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.